Searched for
ANTIBIOTICS SALE
For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...- 16 fixed-dose combination drugs banned in India: Check full list hereFixed dose combination banned full list: India has banned 16 fixed-dose combination drugs, including certain antibiotics and antispasmodics...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- Pharma in her DNA, Wockhardt scion ready for deep dive in the USZahabiya Khorakiwala is leading Wockhardt's US business and the launch of its new antibiotic, Zaynich. This drug targets resistant bacteria...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 26%Just look at developments in the past 48 hours. The war between Iran and Israel resumed, but within hours Tehran said it had halted all off...
- Zaynich's blockbuster potential lifts Wockhardt's long-term outlookWockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...
- If you have the patience, you can achieve innovation milestones, says Wockhardt chairman Habil KhorakiwalaWockhardt Hospitals is set to launch its antibiotic Zaynich in the US. Zahabiya Khorakiwala will lead US operations. The drug is expected t...
- Infosys, Tech Mahindra, TCS and other IT stocks jump up to 5%. What’s driving the rally?Indian IT stocks rose sharply on Monday, lifting the Nifty IT index nearly 3%, as investors reassessed AI-related fears, attracted by attra...
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 22%As the market grappled with confusion over the Strait of Hormuz, there was more trouble for the bulls. After a few days of respite, another...
- Deepa Jewellers, Cotec Healthcare receive Sebi approval for IPOsDeepa Jewellers, a B2B hallmarked gold jewellery processor based in Hyderabad, and Cotec Healthcare, a pharmaceutical CDMO, both received S...
- Pregabalin moved to Schedule H1 as centre cracks down on drug misusePregabalin, a nerve pain medication, now faces stricter controls. The Union health ministry has moved it to Schedule H1. This change aims t...
- HAB Pharma merges Signature Phytochemicals, eyes Rs3,000 crore revenue by 2030HAB Pharma and Signature Phytochemicals have merged, creating a consolidated entity with a turnover of Rs600 crore. This strategic move aim...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- Over 47 per cent antibiotic formulations used in India in 2019 unapproved: Lancet studyThe data were gathered from a panel of 9,000 stockists who store products from approximately 5,000 pharmaceutical companies.
- Covid first wave led to increase in antibiotic misuse in India: StudyThe researchers at Washington University in the US estimated that Covid-19 likely contributed to 216.4 million excess doses of antibiotics ...
- Superbug-related death spurs drug regulator warningThe Centre has also asked state drug regulators to take "strong policy measures including stringent regulatory action on the over-the-count...
- Antibiotic resistance in food-animals growingIndia, long associated with the spread of superbug New Delhi metallo-beta lactamase-1 and extensively drug-resistance tuberculosis, has now...
- WHO seeks to curb menace of drug resistanceIt has asked member-countries, including India, to adopt the classification in their health systems to cut the spread of antimicrobial resi...
- PIL filed in Bombay High Court seeking curbs on antibiotics sale without prescriptionThe petition followed investigation by an activist who found that antibiotics under ‘restricted use’ were freely available over the counter...
- 64% of antibiotics sold in India unapproved, finds UK studyThe report said millions of antibiotic pills in the Indian market have not been regulated in India, the UK or US, worsening the problem of ...
Load More
